BCL2 and breast cancer: Previous studies had identified that expression of BCL2 was associated with improved survival from breast cancer, but this was attributed to its correlation with ER status (Berardo et al, 1998; Charpin et al, 1998; Callagy et al, 2006, 2008; Neri et al, 2006).